Checkpoint inhibitors are drugs that harness the immune system to destroy cancer cells. Let us review what’s been going on in the field.

Q4 2024 Earnings Call Transcript March 11, 2025 Agenus Inc. beats earnings expectations. Reported EPS is $-2.04, expectations ...

Baird lowered the firm’s price target on Agenus (AGEN) to $3 from $6 and keeps a Neutral rating on the shares. The firm updated its model ...

Agenus Inc (AGEN) reports reduced operational burn and promising clinical developments, despite a significant net loss and ...

Good morning, and welcome to Agenus Inc.'s fourth-quarter and year-end 2024 earnings conference call. Currently, all ...

Agenus (AGEN) shares slipped in morning trade after the company missed fourth quarter revenue estimates. The company reported ...

Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), an immuno-oncology company advancing innovative cancer therapies, ...

Agenus (AGEN) delivered earnings and revenue surprises of 13.56% and 20.21%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

LEXINGTON, Mass. (AP) — LEXINGTON, Mass. (AP) — Agenus Inc. (AGEN) on Tuesday reported a loss of $46.8 million in its fourth quarter. The Lexington, Massachusetts-based company said it had a loss of ...

A majority of small- and mid-sized businesses (62%) say they're taking a hit due to the ongoing U.S.-Canada trade war, finds data from the Canadian Federation of Independent Business (CFIB)'s upcoming ...

Twist Bioscience Corporation , a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that, for a limited time, all Twist Express Genes ...